News
Stay up-to-date on our latest news.
Stay up-to-date on our latest news.
May 24, 2023
Clover Expands Sales and Distribution Network for Upcoming Quadrivalent Seasonal Influenza Vaccine Launch in ChinaMar 29, 2023
Clover Announces Corporate Updates and Full Year 2022 Financial ResultsFeb 20, 2023
Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland ChinaFeb 14, 2023
Clover Launches COVID-19 Booster Vaccine in the People's Republic of ChinaJan 16, 2023
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023Nov 30, 2022
Clover's Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious DiseasesOct 09, 2022
Clover Provides Update on 2022 Corporate MilestonesSep 20, 2022
Clover's COVID-19 Vaccine Candidate Receives European Union GMP CertificateSep 20, 2022
Clover's Universal COVID-19 Booster Vaccine Candidate Demonstrates Superior Neutralization of Omicron BA.5 Compared to Inactivated VaccineSep 06, 2022
Clover's COVID-19 Vaccine Candidate Demonstrates Superior Booster Responses Compared to Inactivated Vaccine
